LobbyingDR Peter Ullrich lobbying by quarter
DR Peter Ullrich's latest lobbying report covers Q3 2025, at $10K. Its first report covers Q3 2023; the issues it reports most are Health Issues.
DR Peter Ullrich
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $10K | 1 |
| Q3 2024 | $10K | 1 |
| Q4 2024 | $10K | 1 |
| Q1 2025 | $10K | 1 |
| Q2 2025 | $10K | 1 |
| Q3 2025 | $10K | 1 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$90K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Executive Office of the President (EOP)9 reports
- Health & Human Services, Dept of (HHS)9 reports
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Bell & Lindsay | $90K | 9 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| MARK F LINDSAY | US House Staff | Q3 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/10/20for Q3 2025 | Bell & Lindsay | $10K |
| 25/07/21for Q2 2025 | Bell & Lindsay | $10K |
| 25/04/21for Q1 2025 | Bell & Lindsay | $10K |
| 25/01/21for Q4 2024 | Bell & Lindsay | $10K |
| 24/10/21for Q3 2024 | Bell & Lindsay | $10K |
| 24/07/19for Q2 2024 | Bell & Lindsay | $10K |
| 24/04/19for Q1 2024 | Bell & Lindsay | $10K |
| 24/01/19for Q4 2023 | Bell & Lindsay | $10K |
| 23/11/20for Q3 2023 | Bell & Lindsay | $10K |
| 23/10/20for Q3 2023 | Bell & Lindsay | Under $5,000 |